The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
Open accessAbstract
OBJECTIVE: Lipodystrophy syndromes are extremely rare disorders of deficient body fat associated with potentially serious metabolic complications, including diabetes, hypertriglyceridemia, and steatohepatitis. Due to their rarity, most clinicians are not familiar with their diagnosis and management. This practice guideline summarizes the diagnosis and management of lipodystrophy syndromes not associated with HIV or injectable drugs. PARTICIPANTS: Seventeen participants were nominated by worldwide endocrine societies or selected by the committee as content experts. Funding was via an unrestricted educational grant from Astra Zeneca to the Pediatric Endocrine Society. Meetings were not open to the general public. EVIDENCE: A literature review was conducted by the committee. Recommendations of the committee were graded using the system of the American Heart Association. Expert opinion was used when published data were unavailable or scarce. CONSENSUS PROCESS: The guideline was drafted by committee members and reviewed, revised, and approved by the entire committee during group meetings. Contributing societies reviewed the document and provided approval. CONCLUSIONS: Lipodystrophy syndromes are heterogeneous and are diagnosed by clinical phenotype, supplemented by genetic testing in certain forms. Patients with most lipodystrophy syndromes should be screened for diabetes, dyslipidemia, and liver, kidney, and heart disease annually. Diet is essential for the management of metabolic complications of lipodystrophy. Metreleptin therapy is effective for metabolic complications in hypoleptinemic patients with generalized lipodystrophy and selected patients with partial lipodystrophy. Other treatments not specific for lipodystrophy may be helpful as well (eg, metformin for diabetes, and statins or fibrates for hyperlipidemia). Oral estrogens are contraindicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., et al. (2003) · Nature · doi:10.1038/nature01629 · Cited by 1,990
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
Lamin a truncation in Hutchinson-Gilford progeria
De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C. L., Munnich, A., Le Merrer, M., et al. (2003) · Science · doi:10.1126/science.1084125 · Cited by 1,346
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
Self-citationWalsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,101
Standards of Medical Care in Diabetes—2017 Abridged for Primary Care Providers
American Diabetes Association (2017) · Clinical Diabetes · doi:10.2337/cd16-0067 · Cited by 975
Acquired and Inherited Lipodystrophies
Garg, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra025261 · Cited by 941
Self-citationLeptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800
Self-citationIdentification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13
Magré, J., Delépine, M., Khallouf, E., Gedde-Dahl, T., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Mégarbané, A., BSCL Working Group, et al. (2001) · Nature Genetics · doi:10.1038/ng585 · Cited by 756
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
Shackleton, S., Lloyd, D. J., Jackson, S. N. J., Evans, R., Niermeijer, M. F., Singh, B. M., Schmidt, H., Brabant, G., Kumar, S., Durrington, P. N., et al. (2000) · Nature Genetics · doi:10.1038/72807 · Cited by 704
Cao, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.109 · Cited by 662
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2
George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 559
Self-citationLipodystrophies: Genetic and Acquired Body Fat Disorders
Garg, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1159 · Cited by 557
Self-citationMandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C
Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D’Apice, M. R., Massart, C., Capon, F., Sbraccia, P., Federici, M., Lauro, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341908 · Cited by 553
Jellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
Agarwal, A. K., Arioglu, E., de Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I., & Garg, A. (2002) · Nature Genetics · doi:10.1038/ng880 · Cited by 523
Self-citationStandards of medical care in diabetes—2016 abridged for primary care providers
American Diabetes Association (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.1.3 · Cited by 520
Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia
Agarwal, A. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg213 · Cited by 401
Hayashi, Y. K., Matsuda, C., Ogawa, M., Goto, K., Tominaga, K., Mitsuhashi, S., Park, Y.-E., Nonaka, I., Hino-Fukuyo, N., Haginoya, K., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38660 · Cited by 394
Kim, C. A., Delépine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., Nemani, M., Bridel, E., Leite, C. C., Bertola, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1328 · Cited by 391
Agarwal, A. K., Xing, C., DeMartino, G. N., Mizrachi, D., Hernandez, M. D., Sousa, A. B., Martínez de Villarreal, L., dos Santos, H. G., & Garg, A. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.031 · Cited by 335
Self-citationBoettcher, E., Csako, G., Pucino, F., Wesley, R., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04912.x · Cited by 318
Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy
Gandotra, S., Le Dour, C., Bottomley, W., Cervera, P., Giral, P., Reznik, Y., Charpentier, G., Auclair, M., Delépine, M., Barroso, I., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007487 · Cited by 310
Self-citationEfficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes
Arioglu, E., Duncan-Morin, J., Sebring, N., Rother, K. I., Gottlieb, N., Lieberman, J., Herion, D., Kleiner, D. E., Reynolds, J., Premkumar, A., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-4-200008150-00009 · Cited by 303
Self-citationRubio‐Cabezas, O., Puri, V., Murano, I., Saudek, V., Semple, R. K., Dash, S., Hyden, C. S. S., Bottomley, W., Vigouroux, C., Magré, J., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900037 · Cited by 298
Self-citationMisra, A., Peethambaram, A., & Garg, A. (2004) · Medicine · doi:10.1097/01.md.0000111061.69212.59 · Cited by 285
Self-citationGenotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
Van Maldergem, L., Magré, J., Khallouf, T. E., Gedde-Dahl, T., Delépine, M., Trygstad, O., Seemanova, E., Stephenson, T., Albott, C. S., Bonnici, F., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.10.722 · Cited by 250
Phenotypic and Genetic Heterogeneity in Congenital Generalized Lipodystrophy
Agarwal, A. K., Simha, V., Oral, E. A., Moran, S. A., Gorden, P., O’Rahilly, S., Zaidi, Z., Gurakan, F., Arslanian, S. A., Klar, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030855 · Cited by 246
Self-citationMisra, A., & Garg, A. (2003) · Medicine · doi:10.1097/00005792-200303000-00007 · Cited by 241
Self-citationLessel, D., Vaz, B., Halder, S., Lockhart, P. J., Marinovic-Terzic, I., Lopez-Mosqueda, J., Philipp, M., Sim, J. C. H., Smith, K. R., Oehler, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.3103 · Cited by 236
Ebihara, K., Kusakabe, T., Hirata, M., Masuzaki, H., Miyanaga, F., Kobayashi, N., Tanaka, T., Chusho, H., Miyazawa, T., Hayashi, T., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1546 · Cited by 232
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†
Javor, E. D., Ghany, M. G., Cochran, E. K., Oral, E. A., DePaoli, A. M., Premkumar, A., Kleiner, D. E., & Gorden, P. (2005) · Hepatology · doi:10.1002/hep.20672 · Cited by 228
Self-citationGibbons, R. J., Smith, S., & Antman, E. (2003) · Circulation · doi:10.1161/01.cir.0000063682.20730.a5 · Cited by 203
PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy
Thauvin-Robinet, C., Auclair, M., Duplomb, L., Caron-Debarle, M., Avila, M., St-Onge, J., Le Merrer, M., Le Luyer, B., Héron, D., Mathieu-Dramard, M., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.019 · Cited by 202
Self-citationNull Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes
Albert, J. S., Yerges-Armstrong, L. M., Horenstein, R. B., Pollin, T. I., Sreenivasan, U. T., Chai, S., Blaner, W. S., Snitker, S., O'Connell, J. R., Gong, D.-W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315496 · Cited by 199
Caux, F., Dubosclard, E., Lascols, O., Buendia, B., Chazouillères, O., Cohen, A., Courvalin, J.-C., Laroche, L., Capeau, J., Vigouroux, C., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021506 · Cited by 196
Self-citationGarg, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1776 · Cited by 189
Self-citationBolli, G. B., & Owens, D. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02546-0 · Cited by 186
Weedon, M. N., Ellard, S., Prindle, M. J., Caswell, R., Allen, H. L., Oram, R., Godbole, K., Yajnik, C. S., Sbraccia, P., Novelli, G., et al. (2013) · Nature Genetics · doi:10.1038/ng.2670 · Cited by 185
Simha, V., & Garg, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030835 · Cited by 180
Self-citationDiker-Cohen, T., Cochran, E., Gorden, P., & Brown, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4491 · Cited by 178
Self-citationEfficacy of leptin therapy in the different forms of human lipodystrophy
Chong, A. Y., Lupsa, B. C., Cochran, E. K., & Gorden, P. (2010) · Diabetologia · doi:10.1007/s00125-009-1502-9 · Cited by 177
Payne, F., Lim, K., Girousse, A., Brown, R. J., Kory, N., Robbins, A., Xue, Y., Sleigh, A., Cochran, E., Adams, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408523111 · Cited by 167
Self-citationThe liver diseases of lipodystrophy: The long-term effect of leptin treatment
Safar Zadeh, E., Lungu, A. O., Cochran, E. K., Brown, R. J., Ghany, M. G., Heller, T., Kleiner, D. E., & Gorden, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.007 · Cited by 165
Self-citationMESANGIOCAPILLARY NEPHRITIS, PARTIAL LIPODYSTROPHY, AND HYPOCOMPLEMENTÆMIA
Peters, D. K., Charlesworth, J. A., Sissons, J. G. P., Gwyn Williams, D., Boulton-Jones, J. M., Evans, D. J., Kourilsky, O., & Morel-Maroger, L. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92351-9 · Cited by 158
Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy
Chan, J. L., Lutz, K., Cochran, E. K., Huang, W., Peters, Y., Weyer, C., & Görden, P. (2011) · Endocrine Practice · doi:10.4158/ep11229.or · Cited by 156
New Metabolic Phenotypes in Laminopathies:LMNAMutations in Patients with Severe Metabolic Syndrome
Decaudain, A., Vantyghem, M., Guerci, B., Hécart, A. C., Auclair, M., Reznik, Y., Narbonne, H., Ducluzeau, P., Donadille, B., Lebbé, C., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0654 · Cited by 153
Self-citationCabanillas, R., Cadiñanos, J., Villameytide, J. A. F., Pérez, M., Longo, J., Richard, J. M., Álvarez, R., Durán, N. S., Illán, R., González, D. J., et al. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34249 · Cited by 152
Premature Atherosclerosis Associated With Monogenic Insulin Resistance
Hegele, R. A. (2001) · Circulation · doi:10.1161/01.cir.103.18.2225 · Cited by 151
Musso, C., Cochran, E., Javor, E., Young, J., DePaoli, A. M., & Gorden, P. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.021 · Cited by 146
McDuffie, J. R., Riggs, P. A., Calis, K. A., Freedman, R. J., Oral, E. A., DePaoli, A. M., & Yanovski, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031868 · Cited by 129
Self-citationEffect of Leptin Replacement on Pituitary Hormone Regulation in Patients with Severe Lipodystrophy
Oral, E. A., Ruiz, E., Andewelt, A., Sebring, N., Wagner, A. J., Depaoli, A. M., & Gorden, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8591 · Cited by 129
Self-citationGraivier, M. H., Bass, L. S., Busso, M. E., Jasin, M. E., Narins, R. S., & Tzikas, T. L. (2007) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000285109.34527.b9 · Cited by 125
The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus Statement
Handelsman, Y., Oral, E. A., Bloomgarden, Z. T., Brown, R. J., Chan, J. L., EINHORN, D. F., Garber, A. J., Garg, A., Garvey, W. T., Grunberger, G., et al. (2013) · Endocrine Practice · doi:10.4158/endp.19.1.v767575m65p5mr06 · Cited by 124
Self-citationHigh-dose Insulin Therapy: is it Time for U-500 Insulin?
Lane, W. S., Cochran, E. K., Jackson, J. A., Scism-Bacon, J. L., Corey, I. B., Hirsch, I. B., & Skyler, J. S. (2009) · Endocrine Practice · doi:10.4158/ep.15.1.71 · Cited by 124
Simha, V., Szczepaniak, L. S., Wagner, A. J., DePaoli, A. M., & Garg, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.30 · Cited by 121
Self-citationKöbberling Type of Familial Partial Lipodystrophy
Herbst, K. L., Tannock, L. R., Deeb, S. S., Purnell, J. Q., Brunzell, J. D., & Chait, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1819 · Cited by 119
Masotti, A., Uva, P., Davis‐Keppen, L., Basel‐Vanagaite, L., Cohen, L., Pisaneschi, E., Celluzzi, A., Bencivenga, P., Fang, M., Tian, M., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.12.011 · Cited by 117
Javor, E. D., Moran, S. A., Young, J. R., Cochran, E. K., DePaoli, A. M., Oral, E. A., Turman, M. A., Blackett, P. R., Savage, D. B., O’Rahilly, S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032140 · Cited by 114
Self-citationThe new joint EAS/ESC guidelines for the management of dyslipidaemias
Catapano, A. L., Chapman, J., Wiklund, O., & Taskinen, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.011 · Cited by 111
Fertility and Obstetrical Complications in Women withLMNA-Related Familial Partial Lipodystrophy
Vantyghem, M., Vincent-Desplanques, D., Defrance-Faivre, F., Capeau, J., Fermon, C., Valat, A. S., Lascols, O., Hécart, A. C., Pigny, P., Delemer, B., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2521 · Cited by 98
Self-citationChanges in body composition in patients with severe lipodystrophy after leptin replacement therapy
Moran, S. A., Patten, N., Young, J. R., Cochran, E., Sebring, N., Reynolds, J., Premkumar, A., Depaoli, A. M., Skarulis, M. C., Oral, E. A., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.019 · Cited by 96
Self-citationSimha, V., Subramanyam, L., Szczepaniak, L. S., Quittner, C., ADAMS-HUET, B. A., Snell, P. G., & Garg, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2229 · Cited by 96
Self-citationCardiomyopathy in Congenital and Acquired Generalized Lipodystrophy: A Clinical Assessment
Lupsa, B. C., Sachdev, V., Lungu, A. O., Rosing, D. R., & Görden, P. (2010) · Medicine · doi:10.1097/md.0b013e3181e9442f · Cited by 94
Graul-Neumann, L. M., Kienitz, T., Robinson, P. N., Baasanjav, S., Karow, B., Gillessen‐Kaesbach, G., Fahsold, R., Schmidt, H., Hoffmann, K., & Passarge, E. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33690 · Cited by 90
Farhan, S. M. K., Robinson, J. F., McIntyre, A. D., Marrosu, M. G., Ticca, A. F., Loddo, S., Carboni, N., Brancati, F., & Hegele, R. A. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.007 · Cited by 87
Complement Abnormalities in Acquired Lipodystrophy Revisited
Savage, D. B., Semple, R. K., Clatworthy, M. R., Lyons, P., Morgan, B. P., Cochran, E. K., Görden, P., Raymond‐Barker, P., Murgatroyd, P. R., Adams, C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1703 · Cited by 87
Garg, A., Kircher, M., Campo, M. D., Amato, R. S., & Agarwal, A. K. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37115 · Cited by 81
Self-citationPark, J. Y., Chong, A. Y., Cochran, E. K., Kleiner, D. E., Haller, M. J., Schatz, D., & Görden, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1856 · Cited by 80
Meehan, C. A., Cochran, E. K., Kassai, A., Brown, R. J., & Görden, P. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1096772 · Cited by 75
Self-citationImmunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
Chan, J. L., Koda, J., Heilig, J. S., Cochran, E. K., Gorden, P., Oral, E. A., & Brown, R. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.12980 · Cited by 72
Self-citationHepatic Steatosis in Dunnigan-Type Familial Partial Lipodystrophy
Lüdtke, A., Büttner, J., Brabant, G. E., Bauditz, J., Taupitz, M., Koch, M., Wermke, W., Worman, H. J., & Schmidt, H. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00234.x · Cited by 70
Childhood acquired lipodystrophy: A retrospective study
Pope, E., Janson, A., Khambalia, A., & Feldman, B. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.005 · Cited by 69
Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy
Jackson, S. N. J., Howlett, T. A., McNally, P. C., O’Rahilly, S., & Trembath, R. C. (1997) · QJM · doi:10.1093/qjmed/90.1.27 · Cited by 68
Lungu, A. O., Zadeh, E. S., Goodling, A., Cochran, E. K., & Görden, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1896 · Cited by 65
Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome
Donadille, B., D’anella, P., Auclair, M., Uhrhammer, N. A., Sorel, M., Grigorescu, R., Ouzounian, S., Cambonie, G., Boulot, P., Laforêt, P., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-106 · Cited by 63
Self-citationAn Approach to the Patient with Hirsutism
Loriaux, D. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2744 · Cited by 58
Beltrand, J., Lahlou, N., Charpentier, T. L., Sebag, G. H., Leka, S., Polak, M., Tubiana‐Rufi, N., Lacombe, D., de Kerdanet, M., Huet, F., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1027 · Cited by 58
Aotani, D., Ebihara, K., Sawamoto, N., Kusakabe, T., Aizawa‐Abe, M., Yamamoto‐Kataoka, S., Sakai, T., Iogawa, H., Ebihara, C., Fujikura, J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1872 · Cited by 56
Vatier, C., Fetita, S., Boudou, P., Tchankou, C., Deville, L., Riveline, J., Young, J., Mathivon, L., Travert, F., Morin, D., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12606 · Cited by 56
Self-citationAraújo‐Vilar, D., Sánchez‐Iglesias, S., Guillín‐Amarelle, C., Castro, A., Lage, M., Pazos-Couselo, M., Rial, J. M., Blasco‐Alonso, J., Guillén‐Navarro, E., Jiménez, R. D., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0450-4 · Cited by 50
Leptin Does Not Mediate Hypertension Associated With Human Obesity
Brown, R. J., Meehan, C. A., & Görden, P. (2015) · Cell · doi:10.1016/j.cell.2015.07.007 · Cited by 49
Self-citationSavage, D. B., McFarlane, I., Barroso, I., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1360-4 · Cited by 48
Review article: the management of paediatric nonalcoholic fatty liver disease
Mitchel, E. B., & Lavine, J. E. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12972 · Cited by 48
Araújo-Vilar, D., Lado-Abeal, J., Palos-Paz, F., Lattanzi, G., Bandin, M., Bellido, D., Domínguez-Gerpe, L., Calvo, C., Pérez, O., Ramazanova, A., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03146.x · Cited by 48
Lymphoma in acquired generalized lipodystrophy
Brown, R. J., Chan, J. L., Jaffe, E. S., Cochran, E. K., DePaoli, A. M., Gautier, J., Goujard, C., Vigouroux, C., & Görden, P. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1040015 · Cited by 47
Self-citationEarly hypoglycaemia after accidental intramuscular injection of insulin glargine
Karges, B., Boehm, B. O., & Karges, W. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01654.x · Cited by 46
The effect of diet on thermogenesis in acquired lipodystrophy
Robbins, D. C., Danforth, E., Horton, E. S., Burse, R. L., Goldman, R. F., & Sims, E. A. H. (1979) · Metabolism · doi:10.1016/0026-0495(79)90090-8 · Cited by 45
Dyment, D. A., Gibson, W. T., Huang, L., Bassyouni, H., Hegele, R. A., & Innes, A. M. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.06.006 · Cited by 35
Wilson, D. E., Chan, I.-F., Stevenson, K., Horton, S. C., & SCHIPKE, C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-517 · Cited by 33
Bolan, C. D., Oral, E. A., Görden, P., Taylor, S. I., & Leitman, S. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8176 · Cited by 33
Self-citationThiazolidinedione Response in Familial Lipodystrophy Patients with LMNA Mutations: A Case Series
Luedtke, A., Boschmann, M., Colpe, C., Engeli, S., Adams, F., Birkenfeld, A. L., Haufe, S., Rahn, G., Luft, F. C., Schmidt, H., et al. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1301284 · Cited by 33
Seip, M. (1971) · Springer eBooks · doi:10.1007/978-3-642-65213-4_2 · Cited by 31
Bj�rnstad, P. G., Semb, B. K. H., Trygstad, O., et al. (1985) · European Journal of Pediatrics · doi:10.1007/bf00441777 · Cited by 28
Abel, B. S., Muniyappa, R., Stratton, P., Skarulis, M. C., Görden, P., & Brown, R. J. (2015) · Neuroendocrinology · doi:10.1159/000439432 · Cited by 27
Self-citationInsulin resistance, acanthosis nigricans, and hypertriglyceridemia
Eberting, C. L. D., Javor, E. D., Görden, P., Turner, M. L. C., & Cowen, E. W. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.10.867 · Cited by 26
A Novel Syndrome of Generalized Lipodystrophy Associated With Pilocytic Astrocytoma
Patni, N., Alves, C., von Schnurbein, J., Wabitsch, M., Tannin, G. M., Rakheja, D., & Garg, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2476 · Cited by 23
Self-citationCholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial
Ahmad, Z., Subramanyam, L., Szczepaniak, L. S., Simha, V., ADAMS-HUET, B. A., & Garg, A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0969 · Cited by 23
Self-citationSettergren, J., Eiermann, B., & Mannheimer, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069545 · Cited by 20
Dilated cardiomyopathy and myocardial infarction secondary to congenital generalized lipodystrophy.
Khalife, W. I., Mourtada, M. C., & Khalil, J. (2008) · PubMed · Cited by 10
Casey, S., Lokan, J., Testro, A., Farquharson, S., Connelly, A., Proietto, J., & Angus, P. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12436 · Cited by 9
Familial Hypertriglyceridemia in Children: Dietary Management
Glueck, C. J., Mellies, M. J., Tsang, R. C., Kashyap, M. L., & Steiner, P. M. (1977) · Pediatric Research · doi:10.1203/00006450-197709000-00003 · Cited by 8
Cited by
Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
Kahn, C. R., Wang, G., & Lee, K. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129187 · Cited by 661
Hattersley, A. T., Greeley, S. A. W., Polak, M., Rubio-Cabezas, O., Njølstad, P. R., Mlynarski, W., Castano, L., Carlsson, A., Raile, K., Chi, D. V., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12772 · Cited by 319
Greeley, S. A. W., Polak, M., Njølstad, P. R., Barbetti, F., Williams, R., Castano, L., Raile, K., Chi, D. V., Habeb, A., Hattersley, A. T., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13426 · Cited by 211
Self-citationDiagnosis and treatment of lipodystrophy: a step-by-step approach
Araújo-Vilar, D., & Santini, F. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0887-z · Cited by 194
Self-citationRiddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T. (2020) · Diabetes Care · doi:10.2337/dci20-0065 · Cited by 117
Metadata
- Authors
- Brown, R. J., Araujo-Vilar, D., Cheung, P. T., Dunger, D., Garg, A., Jack, M., Mungai, L., Oral, E. A., Patni, N., Rother, K. I., von Schnurbein, J., Sorkina, E., Stanley, T., Vigouroux, C., Wabitsch, M., Williams, R., & Yorifuji, T.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-12
- Volume
- 101
- Issue
- 12
- Pages
- 4500-4511
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2528176296
- Cited by
- 529
- References
- 106
- FWCI
- 27.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.